Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Think Research Corporation V.THNK

Think Research Corporation is a Canada-based company that offers digital health software solutions. It is a provider of cloud-based data, knowledge, and software solutions primarily delivered as software-as-a-service (SaaS) to healthcare delivery systems and the practitioners that they support. Its operations are organized into three lines of business: Software and Data Solutions, Clinical Research, and Clinical Services. Its SaaS solutions help patients find, navigate, and connect to health services across large governments and payer clients, while also ensuring safety for prescribed medications at pharmacies. Through its wholly owned subsidiary, BioPharma Services Inc., the Company provides research data and analysis derived from Phase I clinical trials, bioequivalence studies and bioanalytical services. Its clinics act as a test bed for its software and technology, transforming them with digital solutions that optimize clinical outcomes, streamline workflows, and optimize billing.


TSXV:THNK - Post by User

Post by dt_coreon Mar 25, 2024 8:16pm
126 Views
Post# 35951941

Seven Business Days Until The Special Meeting

Seven Business Days Until The Special Meeting
Still no word from the company on the results of the Go Shop with only 7 business days remaining until the shareholder vote regarding the Beedie offer. That leaves shareholders in the dark regarding some material facts that make supporting the current deal very difficult such as:
 
1. The number of bidders (if any) that the company was in negotiations with during the Go Shop and the number of bidders that THNK is still in negotiations with. Even if the number is zero that is material information that investors need to know to make an informed voting decision.
 
2. If there are ongoing discussions/negotiations then shareholders should be provided an update on the current status of these negotiations/discussions.
 
3. If there are no negotiations and none expected then BOD should reiterate their support for the Beedie deal that's on the table. Investors are currently in the dark about whether the board is still supportive of the deal and/or if any deal terms, such as the low $0.32 offer, are being renegotiated. Thus, a reiteration of support for the current deal would put the possibility of a modified deal to rest.
 
The other possibility of course is that enough votes have already come in to support the deal, and possibly the BOD feels no sense of accountability to update shareholders. In other words, their attitude may be "It's a done deal, so screw you we don't owe you any explanations for our silence". Of course the other possibility is that negotiations with another party continue to be ongoing hence why the silence or lack of update from the BOD.
 
<< Previous
Bullboard Posts
Next >>